𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial

✍ Scribed by Jorge Sierra; Jeffrey Szer; Jeannine Kassis; Richard Herrmann; Mario Lazzarino; Xavier Thomas; Stephen J Noga; Nigel Baker; Roger Dansey; Alberto Bosi


Book ID
115011298
Publisher
BioMed Central
Year
2008
Tongue
English
Weight
307 KB
Volume
8
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.